These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 36319976)

  • 1. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
    Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
    Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C; Du J; Liu N
    Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer.
    Li L; Li Y; Lin J; Pang W
    Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients.
    Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A
    Adv Genet; 2024; 112():207-254. PubMed ID: 39396837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An age stratified analysis of the biomarkers in patients with colorectal cancer.
    Yao H; Li C; Tan X
    Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer.
    Li Y; Qiu Z; Wang Q; Li S; Zhang Q; Han J
    Biomed Res Int; 2022; 2022():3465391. PubMed ID: 35880031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CLRN3-Based CD8
    Gong Z; Huang X; Cao Q; Wu Y; Zhang Q
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
    Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer.
    Liu R; Wang Y; Bu J; Li Q; Chen F; Zhu M; Chi H; Yu G; Zhu T; Zhu X; Zhao G
    Int J Med Sci; 2024; 21(6):1103-1116. PubMed ID: 38774759
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
    Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
    Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.